High-throughput alternative splicing quantification by primer extension and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

被引:28
作者
McCullough, RM
Cantor, CR
Ding, CM
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Ctr Emerging Infect Dis, Sch Publ Hlth,Fac Med, Shatin, Hong Kong, Peoples R China
[2] Program Mol & Cellular Biol & Biochem, Boston, MA 02215 USA
[3] Ctr Adv Biotechnol, Boston, MA 02215 USA
关键词
D O I
10.1093/nar/gni098
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alternative splicing is a significant contributor to transcriptome diversity, and a high-throughput experimental method to quantitatively assess predictions from expressed sequence tag and microarray analyses may help to answer questions about the extent and functional significance of these variants. Here, we describe a method for high-throughput analysis of known or suspected alternative splicing variants (ASVs) using PCR, primer extension and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). Reverse-transcribed mRNA is PCR amplified with primers surrounding the site of alternative splicing, followed by a primer extension reaction designed to target sequence disparities between two or more variants. These primer extension products are assayed on a MALDI-TOF mass spectrometer and analyzed automatically. This method is high-throughput, highly accurate and reproducible, allowing for the verification of the existence of splicing variants in a variety of samples. An example given also demonstrates how this method can eliminate potential pitfalls from ordinary gel electrophoretic analysis of splicing variants where heteroduplexes formed from different variants can produce erroneous results. The new method can be used to create alternative variant profiles for cancer markers, to study complex splicing regulation, or to screen potential splicing therapies.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 41 条
[1]   IDENTIFICATION OF A SPECIFIC PATTERN OF VASCULAR ENDOTHELIAL GROWTH-FACTOR MESSENGER-RNA EXPRESSION IN HUMAN PLACENTA AND CULTURED PLACENTAL FIBROBLASTS [J].
ANTHONY, FW ;
WHEELER, T ;
ELCOCK, CL ;
PICKETT, M ;
THOMAS, EJ .
PLACENTA, 1994, 15 (05) :557-561
[2]   ABSOLUTE MESSENGER-RNA QUANTIFICATION USING THE POLYMERASE CHAIN-REACTION (PCR) - A NOVEL-APPROACH BY A PCR AIDED TRANSCRIPT TITRATION ASSAY (PATTY) [J].
BECKERANDRE, M ;
HAHLBROCK, K .
NUCLEIC ACIDS RESEARCH, 1989, 17 (22) :9437-9446
[3]   SPLICED SEGMENTS AT 5' TERMINUS OF ADENOVIRUS 2 LATE MESSENGER-RNA [J].
BERGET, SM ;
MOORE, C ;
SHARP, PA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (08) :3171-3175
[4]   The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags [J].
Brentani, H ;
Caballero, OL ;
Camargo, AA ;
da Silva, AM ;
da Silva, WA ;
Neto, ED ;
Grivet, M ;
Gruber, A ;
Guimaraes, PEM ;
Hide, W ;
Iseli, C ;
Jongeneel, CV ;
Kelso, J ;
Nagai, MA ;
Ojopi, EPB ;
Osorio, EC ;
Reis, EMR ;
Riggins, GJ ;
Simpson, AJG ;
de Souza, S ;
Stevenson, BJ ;
Strausberg, RL ;
Tajara, EH ;
Verjovski-Almeida, S ;
Acencion, ML ;
Bengtsono, MH ;
Bettonip, F ;
Bodmerq, WF ;
Brionesr, MRS ;
Camargos, LP ;
Caveneet, W ;
Ceruttiu, JM ;
Coelho Andradev, LE ;
Costa dos Santosn, PC ;
Costaw, MCR ;
da Silvaw, IT ;
Esteciox, MRH ;
Ferreiraw, KS ;
Furnarit, FB ;
Faria, M ;
Galantep, PAF ;
Guimaraesy, GS ;
Holandaw, AJ ;
Kimuraz, ET ;
Leerkesp, MR ;
Xin, LA ;
Macielu, RMB ;
Martinsbb, EAL ;
Massirero, KB ;
Melor, ASA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (23) :13418-13423
[5]  
Cerezo A, 2002, J CELL SCI, V115, P1305
[6]  
Coulson JM, 2000, CANCER RES, V60, P1840
[7]   Pre-mRNA splicing and human disease [J].
Faustino, NA ;
Cooper, TA .
GENES & DEVELOPMENT, 2003, 17 (04) :419-437
[8]   Alternative splicing in disease and therapy [J].
Garcia-Blanco, MA ;
Baraniak, AP ;
Lasda, EL .
NATURE BIOTECHNOLOGY, 2004, 22 (05) :535-546
[9]  
GONZALEZGARCIA M, 1994, DEVELOPMENT, V120, P3033
[10]   Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis [J].
Hicklin, DJ ;
Ellis, LM .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (05) :1011-1027